We use essential cookies and third-party cookies for content.

The National Times - Argentina, Uruguay ratify EU-South America trade deal

Argentina, Uruguay ratify EU-South America trade deal

ECONOMY 26.02.2026
Argentina, Uruguay ratify EU-South America trade deal
Argentina, Uruguay ratify EU-South America trade deal / Photo: © AFP

Argentina on Thursday became the second South American country to ratify a massive trade deal with the European Union that has generated enthusiasm from Brasilia to Buenos Aires but sparked protests and legal challenges in Europe.

Change text size:

Argentine senators voted 69-3 in favor of the agreement to create one of the world's biggest free trade zones, sealing its adoption days after it passed the lower house.

Hours earlier, neighboring Uruguay was first out of the blocks to ratify the deal, which has been fiercely opposed by farmers in some EU countries.

It still requires approval from lawmakers in the European Parliament, which referred it to the EU's top court within days of being inked in January.

The deal between the EU and the four founding members of the Mercosur bloc -- Argentina, Brazil, Paraguay and Uruguay -- was a quarter century in the making.

It eliminates tariffs on more than 90 percent of trade between the two blocs, which together account for 30 percent of global GDP and more than 700 million consumers.

The South Americans have moved to quickly enshrine it in their legislation, in an apparent bid to pressure Brussels to follow suit.

In Brazil, the lower house of parliament backed it by a large majority on Wednesday.

Paraguay has also moved to ratify it.

The accord, which was energetically promoted by EU chief Ursula von der Leyen and Brazilian President Luiz Inacio Lula da Silva as well as the leaders of Germany and Spain, aims to boost EU exports of vehicles, machinery and wines and spirits.

In return, South American producers of meat, sugar, rice, honey and soybeans gain easier access to one of the world's largest economies.

Brussels can decide to implement it provisionally while waiting for an EU court ruling on its legality, but has not yet taken a decision on doing so.

South American countries in the meantime are ploughing ahead.

Uruguayan Foreign Minister Mario Lubetkin hailed his country's ratification on Thursday as "a signal" to Europe, which the South Americans have accused of foot-dragging.

Argentine Senator Francisco Paoltroni hailed the accord as representing "the path to the definitive development of our republic."

Some EU nations hope the pact that could help boost exports at a time of global trade tensions.

France, however, unsuccessfully tried to block the deal over concerns for its farmers, who fear being undercut by cheaper goods from Brazil and its neighbors.

The European Commission reacted to those concerns by adopting a series of safeguards for its producers.

A.Parker--TNT

Featured

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

CapTLX Expands Institutional-Oriented Platform for Access to U.S. Capital Markets

CapTLX, the securities trading and investment platform operated by CHAINLION TECH LTD, today announced the continued expansion of its technology infrastructure for qualified investors and institutional market participants seeking structured access to U.S. equity and private capital markets.

Change text size: